Cryosurgical Ablation for Treatment of Rhinitis: Two-Year Results of a Prospective Multicenter Study

Randall A Ow, Ellen M O'Malley, Joseph K Han, Kent K Lam, David M Yen, Randall A Ow, Ellen M O'Malley, Joseph K Han, Kent K Lam, David M Yen

Abstract

Objectives/hypothesis: To assess the long-term (12-24 months) safety and effectiveness of cryoablation of the posterior nasal nerve as treatment for chronic rhinitis.

Study design: A multicenter, prospective, single-arm clinical study.

Methods: The study was conducted from February 2017 to April 2020. Study endpoints included change from baseline in the reflective Total Nasal Symptom Score (rTNSS), Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), physician assessment of improvement using the Clinical Global Impression-Improvement (CGI-I), and the incidence of treatment-related adverse events.

Results: Ninety-one participants completed the study through the initial 12-month study period. Sixty-two participants consented to the long-term follow-up with 57 completing the 24-month follow-up. Significant improvements in the total rTNSS were reflected in a median change from baseline of -3.0 or -4.0 at all timepoints (P < .001). Greater than 80.0% of participants achieved the minimum clinically important difference (MCID) of improvement by ≥1 point on the rTNSS at all follow-ups. Total RQLQ scores indicated significant improvement (P < .0001) in quality of life. Over 77% of participants achieved the MCID (≥0.5 points) for the total RQLQ score. According to the CGI-I, ≥83.0% experienced improvement at all but the 12-month visit (61.9%). One participant experienced two treatment-related serious adverse events (epistaxis and retained pledget). A total of 29 nonserious treatment-related AEs were reported in 23 participants; most events were transient and resolved with little to no intervention.

Conclusions: Cryotherapy significantly and clinically improves rhinitis symptoms and quality of life with outcomes that are durable through 24 months after treatment.

Level of evidence: 4 Laryngoscope, 131:1952-1957, 2021.

Keywords: Allergic rhinitis; chronic rhinitis; cryotherapy; nonallergic rhinitis; posterior nasal nerve cryoablation.

© 2021 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.

Figures

Fig. 1
Fig. 1
Change in median total reflective Total Nasal Symptom Score (rTNSS) over time. Error bars indicate the interquartile range at each time point. Follow‐up periods through 9 months were reported previously by Chang et al.
Fig. 2
Fig. 2
Clinical global impression of improvement (CGI–I). The CGI–I is a physician‐completed survey indicating the perception of patient improvement compared with baseline. The any improvement category is the sum of the very much improved, much improved, and minimally improved categories.

References

    1. Settipane RA. Epidemiology of vasomotor rhinitis. World Allergy Organ J 2009;2:115–118. [Values updated for 2020 world population estimate of 7.8 billion].
    1. Vandenplas I, Vinnikov D, Blanc PD, et al. Impact of rhinitis on work productivity: a systematic review. J Allergy Clin Immunol Pract 2018;6:1274–1286.
    1. Yan CH, Hwang PH. Surgical management of nonallergic rhinitis. Otolaryngol Clin North Am 2018;51:945–955.
    1. Kompelli AR, Janz TA, Rowan NR, Nguyen SA, Soler ZM. Cryotherapy for the treatment of chronic rhinitis: a qualitative systematic review. Am J Rhinol Allergy 2018;32:491–501.
    1. Hwang PH, Lin B, Weiss R, Atkins J, Johnson J. Cryosurgical posterior nasal tissue ablation for the treatment of rhinitis. Int Forum Allergy Rhinol 2017;7:952–956.
    1. Chang MT, Song S, Hwang PH. Cryosurgical ablation for treatment of rhinitis: a prospective multicenter study. Laryngoscope 2020;130:1877–1884.
    1. Hsu M. Significance of clinical treatments on peripheral nerve and its effect on nerve regeneration. J Neurol Disord 2014;2:100168.
    1. Fawcett JW, Keynes RJ. Peripheral nerve regeneration. Annu Rev Neurosci 1990;13:43–60.
    1. Downie SR, Andersson M, Rimmer J, et al. Symptoms of persistent allergic rhinitis during a full calendar year in house dust mite‐sensitive subjects. Allergy 2004;59:406–414.
    1. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:77–83.
    1. Guy W, ed. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare; Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration; 1976.
    1. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996;98:843–845.
    1. Yen DM, Conley DB, O'Malley EM, Byerly TA, Johnson J. Multiple site cryoablation treatment of the posterior nasal nerve for treatment of chronic rhinitis: an observational feasibility study. Allergy Rhinol 2020;11:1–7. 10.1177/2152656720946996.
    1. Rudmik L, Soler ZM, Mace JC, DeConde AS, Schlosser RJ, Smith TL. Using preoperative SNOT‐22 score to inform patient decision for endoscopic sinus surgery. Laryngoscope 2015;125:1517–1522.

Source: PubMed

3
S'abonner